Apixaban versus Aspirin for Embolic Stroke of Undetermined Source

Tobias Geisler(University Children's Hospital Tübingen), Sven Poli(Hertie Institute for Clinical Brain Research), Jan Purrucker(Heidelberg University), A. Lindner(Marienhospital Stuttgart), Jan Liman(University of Göttingen), Gabor C. Petzold(University Hospital Bonn), L. Niehaus(Rems-Murr-Klinikum), Lina María Serna-­Higuita(University of Tübingen), Hansjörg Bäzner(Klinikum Stuttgart), Jüergen Schreieck(University of Tübingen), Felix J. Bode(University Hospital Bonn), Regina Feurer(Klinikum Ludwigshafen), Brian Mac Grory(Duke University), Hubert Kimmig(Schwarzwald-Baar Klinikum), Thomas Nägele(University of Tübingen), Roman Huber(University of Freiburg), Peter Martus(University of Tübingen), Marc E. Wolf(Heidelberg University), Thanh N. Nguyen(Cleveland Clinic), Khouloud Poli(Hertie Institute for Clinical Brain Research), Paula Bombach(Hertie Institute for Clinical Brain Research), Uwe Klose(University of Tübingen), Werner Jung(Schwarzwald-Baar Klinikum), Timea Keller(University of Tübingen), Ulf Ziemann(University of Tübingen), Katharina Althaus(University Hospital Ulm), Meinrad Gawaz(University of Tübingen), Matthew Schrag(Vanderbilt University Medical Center), Patrick Groga‐Bada(University of Tübingen), Rolf Wachter(Universitätsmedizin Göttingen), Johannes Tünnerhoff(Hertie Institute for Clinical Brain Research), Katrin Naupold(Merseburg University of Applied Sciences), Carsten Hobohm(Merseburg University of Applied Sciences), Frank Hoffmann(Martha-Maria Hospital), Parwez Aidery(University of Tübingen), Andrea Kraft(Martha-Maria Hospital), Christine S. Zuern(University Hospital of Basel)
NEJM Evidence
December 22, 2023
Cited by 80


Related Papers